Last reviewed · How we verify
Pasireotide ampule with syringe — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Pasireotide ampule with syringe (Pasireotide ampule with syringe) — RECORDATI GROUP.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pasireotide ampule with syringe TARGET | Pasireotide ampule with syringe | RECORDATI GROUP | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pasireotide ampule with syringe CI watch — RSS
- Pasireotide ampule with syringe CI watch — Atom
- Pasireotide ampule with syringe CI watch — JSON
- Pasireotide ampule with syringe alone — RSS
Cite this brief
Drug Landscape (2026). Pasireotide ampule with syringe — Competitive Intelligence Brief. https://druglandscape.com/ci/pasireotide-ampule-with-syringe. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab